Page 5 - Remunity Pump News Today

Russell Investments Group Ltd. lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 12.4% in the second quarter, HoldingsChannel.com reports. The firm owned 116,338 shares of the biotechnology company’s stock after selling 16,450 shares during the period. Russell Investments Group Ltd.’s holdings in United Therapeutics were worth $25,682,000 as of […]

Rhumbline Advisers raised its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 5.2% during the second quarter, Holdings Channel.com reports. The firm owned 140,779 shares of the biotechnology company’s stock after purchasing an additional 6,997 shares during the quarter. Rhumbline Advisers’ holdings in United Therapeutics were worth $31,077,000 as of its most recent […]

United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Thursday. Several other equities analysts also recently commented on UTHR. Morgan Stanley increased their target price on United Therapeutics from $316.00 to $318.00 and gave the […]

Operator: Good morning, and welcome to the United Therapeutics Corporation Third Quarter 2023 Earnings Webcast. My name is Rocco, and I will be your conference operator today.

United Therapeutics (NASDAQ:UTHR – Get Free Report) will be announcing its 09/30/2023 earnings results before the market opens on Wednesday, November 1st. Analysts expect the company to announce earnings of $4.88 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. United Therapeutics (NASDAQ:UTHR – […]

Coldstream Capital Management Inc. grew its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,094 shares of the biotechnology company’s stock after purchasing an additional 86 shares during the period. Coldstream […]

StockNews.com assumed coverage on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a research report released on Thursday morning. The firm issued a buy rating on the biotechnology company’s stock. UTHR has been the topic of a number of other research reports. HC Wainwright restated a buy rating and set a $300.00 price objective […]

TFB Advisors LLC increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 28.3% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,954 shares of the biotechnology company’s stock after acquiring an additional 431 shares during the quarter. […]

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the business’s stock in a transaction that occurred on Thursday, September 21st. The shares were sold at an average price of $222.19, for a total value of $1,333,140.00. Following the completion of the sale, the executive vice president now […]

Harel Insurance Investments & Financial Services Ltd. lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 36.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 10,051 shares of the biotechnology company’s stock after selling 5,841 shares during the quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in […]